InvestorsHub Logo
Followers 276
Posts 32697
Boards Moderated 0
Alias Born 11/14/2013

Re: Astavakra post# 3440

Saturday, 01/18/2014 11:49:52 PM

Saturday, January 18, 2014 11:49:52 PM

Post# of 699744
Astavraka,


Graph cutting was a visualization. Despite the temptation to plug current numbers in to reach a statistical educated guess, the posters here admit there are not enough data points. That is where art, science, history and 'weather patterns' leave room for human intuition. 2 Days ago I relearned statistical analysis, and it is amazing when you have enough data. If you don't, you must use inductive and deductive reasoning from multiple disciplines -- including statistics. I do not claim to know what is going to happen, and neither do the other bright people here. However, we all agree, from different backgrounds, that the dream is still alive.


In the event of a successful DMC review, NWBO is supremely positioned for a lightning bolt FDA application and launch. Their price point and platform for all operable solid tumor cancers will change the world. Their manufacturing ramp will be disciplined and already possesses preplanned potential capacity.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News